- Home
- CRNX vs PFSI Comparison
CRNX vs PFSI Comparison
Compare CRNX & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRNX | PFSI |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.8B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CRNX | PFSI |
|---|---|---|
| Price | $38.57 | $86.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $74.78 | ★ $139.13 |
| AVG Volume (30 Days) | ★ 935.7K | 856.1K |
| Earning Date | 06-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.35% |
| EPS Growth | N/A | ★ 59.25 |
| EPS | N/A | ★ 9.30 |
| Revenue | $1,039,000.00 | ★ $984,629,000.00 |
| Revenue This Year | $730.30 | N/A |
| Revenue Next Year | $179.48 | $15.35 |
| P/E Ratio | ★ N/A | $9.56 |
| Revenue Growth | N/A | ★ 3.05 |
| 52 Week Low | $24.10 | $85.74 |
| 52 Week High | $57.99 | $160.36 |
Technical Indicators
Market Signals| Indicator | CRNX | PFSI |
|---|---|---|
| Relative Strength Index (RSI) | 26.18 | 26.86 |
| Support Level | $33.23 | N/A |
| Resistance Level | $45.32 | $104.03 |
| Average True Range (ATR) | 1.87 | 2.77 |
| MACD | -0.40 | 1.11 |
| Stochastic Oscillator | 6.93 | 13.91 |
Price Performance
Historical ComparisonAbout CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.